AUSTIN, Texas--(BUSINESS WIRE)--Spinal Restoration, Inc., a privately held spine company based in Austin, announced today that it has closed a $16 million Series B round of equity financing. Santé Health Ventures and MB Venture Partners joined Series A lead and founding investors Austin Ventures and Path4 Ventures in the round. Spinal Restoration will utilize the funds to complete an IDE clinical trial of the Biostat™ Disc Augmentation System, a new minimally invasive, biologic treatment for discogenic low back pain.
